Medical Care
Global Adults Genetic Disease Diagnosis Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 16, 25
- ID: 551666
- Pages: 127
- Figures: 120
- Views: 3
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Adults Genetic Disease Diagnosis market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Segment by Application
Hospital
Medical Laboratory
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Adults Genetic Disease Diagnosis study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Adults Genetic Disease Diagnosis market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Segment by Application
Hospital
Medical Laboratory
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Adults Genetic Disease Diagnosis study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Adults Genetic Disease Diagnosis: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Adults Genetic Disease Diagnosis Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Adults Genetic Disease Diagnosis Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Adults Genetic Disease Diagnosis Revenue Estimates and Forecasts 2020-2031
2.2 Global Adults Genetic Disease Diagnosis Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Adults Genetic Disease Diagnosis Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Adults Genetic Disease Diagnosis Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Prenatal Diagnosis Market Size by Players
3.3.2 Screening for Single Gene Genetic Disease Market Size by Players
3.3.3 Preimplantation Genetic Testing Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Adults Genetic Disease Diagnosis Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Adults Genetic Disease Diagnosis Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Adults Genetic Disease Diagnosis Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)
6.4 North America Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Adults Genetic Disease Diagnosis Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)
7.4 Europe Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Adults Genetic Disease Diagnosis Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)
8.4 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)
9.4 Central and South America Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Adults Genetic Disease Diagnosis Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)
10.4 Middle East and Africa Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Adults Genetic Disease Diagnosis Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Adults Genetic Disease Diagnosis Product Features and Attributes
11.1.4 Abbott Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Adults Genetic Disease Diagnosis Revenue by Product in 2024
11.1.6 Abbott Adults Genetic Disease Diagnosis Revenue by Application in 2024
11.1.7 Abbott Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024
11.1.8 Abbott Adults Genetic Disease Diagnosis SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Corporation Information
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Adults Genetic Disease Diagnosis Product Features and Attributes
11.2.4 PerkinElmer Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.2.5 PerkinElmer Adults Genetic Disease Diagnosis Revenue by Product in 2024
11.2.6 PerkinElmer Adults Genetic Disease Diagnosis Revenue by Application in 2024
11.2.7 PerkinElmer Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024
11.2.8 PerkinElmer Adults Genetic Disease Diagnosis SWOT Analysis
11.2.9 PerkinElmer Recent Developments
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Corporation Information
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Adults Genetic Disease Diagnosis Product Features and Attributes
11.3.4 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.3.5 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue by Product in 2024
11.3.6 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue by Application in 2024
11.3.7 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024
11.3.8 Roche Diagnostics Adults Genetic Disease Diagnosis SWOT Analysis
11.3.9 Roche Diagnostics Recent Developments
11.4 Bio Rad
11.4.1 Bio Rad Corporation Information
11.4.2 Bio Rad Business Overview
11.4.3 Bio Rad Adults Genetic Disease Diagnosis Product Features and Attributes
11.4.4 Bio Rad Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.4.5 Bio Rad Adults Genetic Disease Diagnosis Revenue by Product in 2024
11.4.6 Bio Rad Adults Genetic Disease Diagnosis Revenue by Application in 2024
11.4.7 Bio Rad Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024
11.4.8 Bio Rad Adults Genetic Disease Diagnosis SWOT Analysis
11.4.9 Bio Rad Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Corporation Information
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Product Features and Attributes
11.5.4 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.5.5 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue by Product in 2024
11.5.6 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue by Application in 2024
11.5.7 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024
11.5.8 Thermo Fisher Scientific Adults Genetic Disease Diagnosis SWOT Analysis
11.5.9 Thermo Fisher Scientific Recent Developments
11.6 BGI Group
11.6.1 BGI Group Corporation Information
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Adults Genetic Disease Diagnosis Product Features and Attributes
11.6.4 BGI Group Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.6.5 BGI Group Recent Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Corporation Information
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Adults Genetic Disease Diagnosis Product Features and Attributes
11.7.4 Berry Genomics Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.7.5 Berry Genomics Recent Developments
11.8 Da An Gene Co., Ltd.
11.8.1 Da An Gene Co., Ltd. Corporation Information
11.8.2 Da An Gene Co., Ltd. Business Overview
11.8.3 Da An Gene Co., Ltd. Adults Genetic Disease Diagnosis Product Features and Attributes
11.8.4 Da An Gene Co., Ltd. Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.8.5 Da An Gene Co., Ltd. Recent Developments
11.9 Illumina
11.9.1 Illumina Corporation Information
11.9.2 Illumina Business Overview
11.9.3 Illumina Adults Genetic Disease Diagnosis Product Features and Attributes
11.9.4 Illumina Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.9.5 Illumina Recent Developments
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Corporation Information
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Adults Genetic Disease Diagnosis Product Features and Attributes
11.10.4 CapitalBio Technology Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Adults Genetic Disease DiagnosisIndustry Chain Analysis
12.1 Adults Genetic Disease Diagnosis Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Adults Genetic Disease Diagnosis Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Adults Genetic Disease Diagnosis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Adults Genetic Disease Diagnosis: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Adults Genetic Disease Diagnosis Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Prenatal Diagnosis
1.2.3 Screening for Single Gene Genetic Disease
1.2.4 Preimplantation Genetic Testing
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Adults Genetic Disease Diagnosis Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Adults Genetic Disease Diagnosis Revenue Estimates and Forecasts 2020-2031
2.2 Global Adults Genetic Disease Diagnosis Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Adults Genetic Disease Diagnosis Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Adults Genetic Disease Diagnosis Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Prenatal Diagnosis Market Size by Players
3.3.2 Screening for Single Gene Genetic Disease Market Size by Players
3.3.3 Preimplantation Genetic Testing Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Adults Genetic Disease Diagnosis Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Adults Genetic Disease Diagnosis Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Adults Genetic Disease Diagnosis Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)
6.4 North America Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Adults Genetic Disease Diagnosis Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)
7.4 Europe Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Adults Genetic Disease Diagnosis Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)
8.4 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)
9.4 Central and South America Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Adults Genetic Disease Diagnosis Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)
10.4 Middle East and Africa Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Adults Genetic Disease Diagnosis Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Adults Genetic Disease Diagnosis Product Features and Attributes
11.1.4 Abbott Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Adults Genetic Disease Diagnosis Revenue by Product in 2024
11.1.6 Abbott Adults Genetic Disease Diagnosis Revenue by Application in 2024
11.1.7 Abbott Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024
11.1.8 Abbott Adults Genetic Disease Diagnosis SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Corporation Information
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Adults Genetic Disease Diagnosis Product Features and Attributes
11.2.4 PerkinElmer Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.2.5 PerkinElmer Adults Genetic Disease Diagnosis Revenue by Product in 2024
11.2.6 PerkinElmer Adults Genetic Disease Diagnosis Revenue by Application in 2024
11.2.7 PerkinElmer Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024
11.2.8 PerkinElmer Adults Genetic Disease Diagnosis SWOT Analysis
11.2.9 PerkinElmer Recent Developments
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Corporation Information
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Adults Genetic Disease Diagnosis Product Features and Attributes
11.3.4 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.3.5 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue by Product in 2024
11.3.6 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue by Application in 2024
11.3.7 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024
11.3.8 Roche Diagnostics Adults Genetic Disease Diagnosis SWOT Analysis
11.3.9 Roche Diagnostics Recent Developments
11.4 Bio Rad
11.4.1 Bio Rad Corporation Information
11.4.2 Bio Rad Business Overview
11.4.3 Bio Rad Adults Genetic Disease Diagnosis Product Features and Attributes
11.4.4 Bio Rad Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.4.5 Bio Rad Adults Genetic Disease Diagnosis Revenue by Product in 2024
11.4.6 Bio Rad Adults Genetic Disease Diagnosis Revenue by Application in 2024
11.4.7 Bio Rad Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024
11.4.8 Bio Rad Adults Genetic Disease Diagnosis SWOT Analysis
11.4.9 Bio Rad Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Corporation Information
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Product Features and Attributes
11.5.4 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.5.5 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue by Product in 2024
11.5.6 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue by Application in 2024
11.5.7 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024
11.5.8 Thermo Fisher Scientific Adults Genetic Disease Diagnosis SWOT Analysis
11.5.9 Thermo Fisher Scientific Recent Developments
11.6 BGI Group
11.6.1 BGI Group Corporation Information
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Adults Genetic Disease Diagnosis Product Features and Attributes
11.6.4 BGI Group Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.6.5 BGI Group Recent Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Corporation Information
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Adults Genetic Disease Diagnosis Product Features and Attributes
11.7.4 Berry Genomics Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.7.5 Berry Genomics Recent Developments
11.8 Da An Gene Co., Ltd.
11.8.1 Da An Gene Co., Ltd. Corporation Information
11.8.2 Da An Gene Co., Ltd. Business Overview
11.8.3 Da An Gene Co., Ltd. Adults Genetic Disease Diagnosis Product Features and Attributes
11.8.4 Da An Gene Co., Ltd. Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.8.5 Da An Gene Co., Ltd. Recent Developments
11.9 Illumina
11.9.1 Illumina Corporation Information
11.9.2 Illumina Business Overview
11.9.3 Illumina Adults Genetic Disease Diagnosis Product Features and Attributes
11.9.4 Illumina Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.9.5 Illumina Recent Developments
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Corporation Information
11.10.2 CapitalBio Technology Business Overview
11.10.3 CapitalBio Technology Adults Genetic Disease Diagnosis Product Features and Attributes
11.10.4 CapitalBio Technology Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Adults Genetic Disease DiagnosisIndustry Chain Analysis
12.1 Adults Genetic Disease Diagnosis Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Adults Genetic Disease Diagnosis Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Adults Genetic Disease Diagnosis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Adults Genetic Disease Diagnosis Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Adults Genetic Disease Diagnosis Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Adults Genetic Disease Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Adults Genetic Disease Diagnosis Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Adults Genetic Disease Diagnosis by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adults Genetic Disease Diagnosis as of 2024)
Table 11. Global Adults Genetic Disease Diagnosis Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Adults Genetic Disease Diagnosis Companies Headquarters
Table 13. Global Adults Genetic Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Adults Genetic Disease Diagnosis Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Adults Genetic Disease Diagnosis Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Adults Genetic Disease Diagnosis Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Adults Genetic Disease Diagnosis Revenue by Application (2026-2031) & (US$ Million)
Table 21. Adults Genetic Disease Diagnosis High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Adults Genetic Disease Diagnosis Growth Accelerators and Market Barriers
Table 25. North America Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Adults Genetic Disease Diagnosis Growth Accelerators and Market Barriers
Table 27. Europe Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Adults Genetic Disease Diagnosis Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Adults Genetic Disease Diagnosis Investment Opportunities and Key Challenges
Table 31. Central and South America Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Adults Genetic Disease Diagnosis Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Abbott Corporation Information
Table 35. Abbott Description and Major Businesses
Table 36. Abbott Product Features and Attributes
Table 37. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Abbott Revenue Proportion by Product in 2024
Table 39. Abbott Revenue Proportion by Application in 2024
Table 40. Abbott Revenue Proportion by Geographic Area in 2024
Table 41. Abbott Adults Genetic Disease Diagnosis SWOT Analysis
Table 42. Abbott Recent Developments
Table 43. PerkinElmer Corporation Information
Table 44. PerkinElmer Description and Major Businesses
Table 45. PerkinElmer Product Features and Attributes
Table 46. PerkinElmer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. PerkinElmer Revenue Proportion by Product in 2024
Table 48. PerkinElmer Revenue Proportion by Application in 2024
Table 49. PerkinElmer Revenue Proportion by Geographic Area in 2024
Table 50. PerkinElmer Adults Genetic Disease Diagnosis SWOT Analysis
Table 51. PerkinElmer Recent Developments
Table 52. Roche Diagnostics Corporation Information
Table 53. Roche Diagnostics Description and Major Businesses
Table 54. Roche Diagnostics Product Features and Attributes
Table 55. Roche Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Roche Diagnostics Revenue Proportion by Product in 2024
Table 57. Roche Diagnostics Revenue Proportion by Application in 2024
Table 58. Roche Diagnostics Revenue Proportion by Geographic Area in 2024
Table 59. Roche Diagnostics Adults Genetic Disease Diagnosis SWOT Analysis
Table 60. Roche Diagnostics Recent Developments
Table 61. Bio Rad Corporation Information
Table 62. Bio Rad Description and Major Businesses
Table 63. Bio Rad Product Features and Attributes
Table 64. Bio Rad Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Bio Rad Revenue Proportion by Product in 2024
Table 66. Bio Rad Revenue Proportion by Application in 2024
Table 67. Bio Rad Revenue Proportion by Geographic Area in 2024
Table 68. Bio Rad Adults Genetic Disease Diagnosis SWOT Analysis
Table 69. Bio Rad Recent Developments
Table 70. Thermo Fisher Scientific Corporation Information
Table 71. Thermo Fisher Scientific Description and Major Businesses
Table 72. Thermo Fisher Scientific Product Features and Attributes
Table 73. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 75. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 76. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 77. Thermo Fisher Scientific Adults Genetic Disease Diagnosis SWOT Analysis
Table 78. Thermo Fisher Scientific Recent Developments
Table 79. BGI Group Corporation Information
Table 80. BGI Group Description and Major Businesses
Table 81. BGI Group Product Features and Attributes
Table 82. BGI Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. BGI Group Recent Developments
Table 84. Berry Genomics Corporation Information
Table 85. Berry Genomics Description and Major Businesses
Table 86. Berry Genomics Product Features and Attributes
Table 87. Berry Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Berry Genomics Recent Developments
Table 89. Da An Gene Co., Ltd. Corporation Information
Table 90. Da An Gene Co., Ltd. Description and Major Businesses
Table 91. Da An Gene Co., Ltd. Product Features and Attributes
Table 92. Da An Gene Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Da An Gene Co., Ltd. Recent Developments
Table 94. Illumina Corporation Information
Table 95. Illumina Description and Major Businesses
Table 96. Illumina Product Features and Attributes
Table 97. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Illumina Recent Developments
Table 99. CapitalBio Technology Corporation Information
Table 100. CapitalBio Technology Description and Major Businesses
Table 101. CapitalBio Technology Product Features and Attributes
Table 102. CapitalBio Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. CapitalBio Technology Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Adults Genetic Disease Diagnosis Product Picture
Figure 2. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Prenatal Diagnosis Product Picture
Figure 4. Screening for Single Gene Genetic Disease Product Picture
Figure 5. Preimplantation Genetic Testing Product Picture
Figure 6. Others Product Picture
Figure 7. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Medical Laboratory
Figure 10. Others
Figure 11. Adults Genetic Disease Diagnosis Report Years Considered
Figure 12. Global Adults Genetic Disease Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 14. Global Adults Genetic Disease Diagnosis Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Adults Genetic Disease Diagnosis Revenue Market Share by Region (2020-2031)
Figure 16. Global Adults Genetic Disease Diagnosis Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Prenatal Diagnosis Revenue Market Share by Player in 2024
Figure 19. Screening for Single Gene Genetic Disease Revenue Market Share by Player in 2024
Figure 20. Preimplantation Genetic Testing Revenue Market Share by Player in 2024
Figure 21. Others Revenue Market Share by Player in 2024
Figure 22. Global Adults Genetic Disease Diagnosis Revenue Market Share by Type (2020-2031)
Figure 23. Global Adults Genetic Disease Diagnosis Revenue Market Share by Application (2020-2031)
Figure 24. North America Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024
Figure 26. North America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024
Figure 33. Europe Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 36. France Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 48. India Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024
Figure 56. Central and South America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024
Figure 62. South America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 68. Adults Genetic Disease Diagnosis Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Adults Genetic Disease Diagnosis Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Adults Genetic Disease Diagnosis Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Adults Genetic Disease Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Adults Genetic Disease Diagnosis Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Adults Genetic Disease Diagnosis by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adults Genetic Disease Diagnosis as of 2024)
Table 11. Global Adults Genetic Disease Diagnosis Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Adults Genetic Disease Diagnosis Companies Headquarters
Table 13. Global Adults Genetic Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Adults Genetic Disease Diagnosis Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Adults Genetic Disease Diagnosis Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Adults Genetic Disease Diagnosis Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Adults Genetic Disease Diagnosis Revenue by Application (2026-2031) & (US$ Million)
Table 21. Adults Genetic Disease Diagnosis High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Adults Genetic Disease Diagnosis Growth Accelerators and Market Barriers
Table 25. North America Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Adults Genetic Disease Diagnosis Growth Accelerators and Market Barriers
Table 27. Europe Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Adults Genetic Disease Diagnosis Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Adults Genetic Disease Diagnosis Investment Opportunities and Key Challenges
Table 31. Central and South America Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Adults Genetic Disease Diagnosis Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Abbott Corporation Information
Table 35. Abbott Description and Major Businesses
Table 36. Abbott Product Features and Attributes
Table 37. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Abbott Revenue Proportion by Product in 2024
Table 39. Abbott Revenue Proportion by Application in 2024
Table 40. Abbott Revenue Proportion by Geographic Area in 2024
Table 41. Abbott Adults Genetic Disease Diagnosis SWOT Analysis
Table 42. Abbott Recent Developments
Table 43. PerkinElmer Corporation Information
Table 44. PerkinElmer Description and Major Businesses
Table 45. PerkinElmer Product Features and Attributes
Table 46. PerkinElmer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. PerkinElmer Revenue Proportion by Product in 2024
Table 48. PerkinElmer Revenue Proportion by Application in 2024
Table 49. PerkinElmer Revenue Proportion by Geographic Area in 2024
Table 50. PerkinElmer Adults Genetic Disease Diagnosis SWOT Analysis
Table 51. PerkinElmer Recent Developments
Table 52. Roche Diagnostics Corporation Information
Table 53. Roche Diagnostics Description and Major Businesses
Table 54. Roche Diagnostics Product Features and Attributes
Table 55. Roche Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Roche Diagnostics Revenue Proportion by Product in 2024
Table 57. Roche Diagnostics Revenue Proportion by Application in 2024
Table 58. Roche Diagnostics Revenue Proportion by Geographic Area in 2024
Table 59. Roche Diagnostics Adults Genetic Disease Diagnosis SWOT Analysis
Table 60. Roche Diagnostics Recent Developments
Table 61. Bio Rad Corporation Information
Table 62. Bio Rad Description and Major Businesses
Table 63. Bio Rad Product Features and Attributes
Table 64. Bio Rad Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Bio Rad Revenue Proportion by Product in 2024
Table 66. Bio Rad Revenue Proportion by Application in 2024
Table 67. Bio Rad Revenue Proportion by Geographic Area in 2024
Table 68. Bio Rad Adults Genetic Disease Diagnosis SWOT Analysis
Table 69. Bio Rad Recent Developments
Table 70. Thermo Fisher Scientific Corporation Information
Table 71. Thermo Fisher Scientific Description and Major Businesses
Table 72. Thermo Fisher Scientific Product Features and Attributes
Table 73. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 75. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 76. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 77. Thermo Fisher Scientific Adults Genetic Disease Diagnosis SWOT Analysis
Table 78. Thermo Fisher Scientific Recent Developments
Table 79. BGI Group Corporation Information
Table 80. BGI Group Description and Major Businesses
Table 81. BGI Group Product Features and Attributes
Table 82. BGI Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. BGI Group Recent Developments
Table 84. Berry Genomics Corporation Information
Table 85. Berry Genomics Description and Major Businesses
Table 86. Berry Genomics Product Features and Attributes
Table 87. Berry Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Berry Genomics Recent Developments
Table 89. Da An Gene Co., Ltd. Corporation Information
Table 90. Da An Gene Co., Ltd. Description and Major Businesses
Table 91. Da An Gene Co., Ltd. Product Features and Attributes
Table 92. Da An Gene Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Da An Gene Co., Ltd. Recent Developments
Table 94. Illumina Corporation Information
Table 95. Illumina Description and Major Businesses
Table 96. Illumina Product Features and Attributes
Table 97. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Illumina Recent Developments
Table 99. CapitalBio Technology Corporation Information
Table 100. CapitalBio Technology Description and Major Businesses
Table 101. CapitalBio Technology Product Features and Attributes
Table 102. CapitalBio Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. CapitalBio Technology Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Adults Genetic Disease Diagnosis Product Picture
Figure 2. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Prenatal Diagnosis Product Picture
Figure 4. Screening for Single Gene Genetic Disease Product Picture
Figure 5. Preimplantation Genetic Testing Product Picture
Figure 6. Others Product Picture
Figure 7. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Medical Laboratory
Figure 10. Others
Figure 11. Adults Genetic Disease Diagnosis Report Years Considered
Figure 12. Global Adults Genetic Disease Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 14. Global Adults Genetic Disease Diagnosis Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Adults Genetic Disease Diagnosis Revenue Market Share by Region (2020-2031)
Figure 16. Global Adults Genetic Disease Diagnosis Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Prenatal Diagnosis Revenue Market Share by Player in 2024
Figure 19. Screening for Single Gene Genetic Disease Revenue Market Share by Player in 2024
Figure 20. Preimplantation Genetic Testing Revenue Market Share by Player in 2024
Figure 21. Others Revenue Market Share by Player in 2024
Figure 22. Global Adults Genetic Disease Diagnosis Revenue Market Share by Type (2020-2031)
Figure 23. Global Adults Genetic Disease Diagnosis Revenue Market Share by Application (2020-2031)
Figure 24. North America Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024
Figure 26. North America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024
Figure 33. Europe Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 36. France Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 48. India Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024
Figure 56. Central and South America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024
Figure 62. South America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)
Figure 68. Adults Genetic Disease Diagnosis Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Motor Brush Rocker Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 16, 25
Global Pediatric Mandibular Distractor System Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 16, 25
Global Automatic Coercive Force Meter Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232